Business News/Market/Market Stats/   Sun Pharmaceutical Industries Q4 Results

Sun Pharmaceutical Industries Q4 Results

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs
1,191.40 -5.00 (-0.42%)Updated : 28 Nov 2023
Fiscal Period2023
Period End DateMar 23
Revenue 10930.67
Total Revenue 10930.67
Costof Revenue Total 2250.22
Gross Profit 8680.45
Selling/ General/ Admin Expenses Total 2179.55
Depreciation/ Amortization 671.53
Unusual Expense( Income) 171.45
Other Operating Expenses Total 3671.60
Total Operating Expense 8944.35
Operating Income 1986.32
Interest Inc( Exp) Net- Non- Op Total -1199.10
Other Net 373.28
Net Income Before Taxes 2239.69
Provisionfor Income Taxes 222.91
Net Income After Taxes 2016.78
Minority Interest 1.57
Equity In Affiliates -338.80
Net Income Before Extra Items 1984.47
Net Income 1984.47
Income Availableto Com Excl Extra Ord 1984.47
Income Availableto Com Incl Extra Ord 1984.47
Diluted Net Income 1984.47
Diluted Weighted Average Shares 238.72
Diluted EPS Excluding Extra Ord Items 8.31
DPS- Common Stock Primary Issue 4.00
Diluted Normalized EPS 8.96
*All figures in crores except per share values
Recommended For You